For solid carcinoma, one study on 161 patients who received cyclophosphamide, doxorubicin, and etoposide regimen for small cell lung carcinoma showed 55% reduction of FN incidence with the administration of G-CSF plus prophylactic antibiotics than of G-CSF alone18. Here, CSF3 is linked to small cell lung carcinoma.